SG11202103463RA - Methods for analysis of viral capsid protein composition - Google Patents

Methods for analysis of viral capsid protein composition

Info

Publication number
SG11202103463RA
SG11202103463RA SG11202103463RA SG11202103463RA SG11202103463RA SG 11202103463R A SG11202103463R A SG 11202103463RA SG 11202103463R A SG11202103463R A SG 11202103463RA SG 11202103463R A SG11202103463R A SG 11202103463RA SG 11202103463R A SG11202103463R A SG 11202103463RA
Authority
SG
Singapore
Prior art keywords
analysis
methods
capsid protein
protein composition
viral capsid
Prior art date
Application number
SG11202103463RA
Other languages
English (en)
Inventor
Shunhai Wang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11202103463RA publication Critical patent/SG11202103463RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14142—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G01N2030/062—Preparation extracting sample from raw material
SG11202103463RA 2018-10-25 2019-10-24 Methods for analysis of viral capsid protein composition SG11202103463RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862750583P 2018-10-25 2018-10-25
PCT/US2019/057936 WO2020086893A1 (fr) 2018-10-25 2019-10-24 Procédés d'analyse d'une composition de protéines de capside virale

Publications (1)

Publication Number Publication Date
SG11202103463RA true SG11202103463RA (en) 2021-05-28

Family

ID=68696510

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103463RA SG11202103463RA (en) 2018-10-25 2019-10-24 Methods for analysis of viral capsid protein composition

Country Status (14)

Country Link
US (3) US11345929B2 (fr)
EP (2) EP4306961A3 (fr)
JP (2) JP7439077B2 (fr)
KR (1) KR20210082183A (fr)
CN (2) CN117969861A (fr)
AU (1) AU2019366983A1 (fr)
BR (1) BR112021007550A2 (fr)
CA (1) CA3115832A1 (fr)
EA (1) EA202191137A1 (fr)
IL (1) IL282411A (fr)
MX (1) MX2021004533A (fr)
PL (1) PL3870976T3 (fr)
SG (1) SG11202103463RA (fr)
WO (1) WO2020086893A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021127309A1 (fr) * 2019-12-20 2021-06-24 University Of Maryland, Baltimore Quantification non invasive de capsides pleines vs. vides au moyen de la rmn du proton de l'eau
US20240052322A1 (en) * 2020-12-15 2024-02-15 Pfizer Inc. HILIC UPLC-MS Method For Separating and Analyzing Intact Adeno-Associated Virus Capsid Proteins
TWI829131B (zh) * 2021-09-28 2024-01-11 美商索特拉科技公司 用於淘選材料之方法和系統以及儲存在電腦可讀儲存媒體上的電腦程式產品
WO2023207918A1 (fr) * 2022-04-25 2023-11-02 Beijing Hanmoluojie Technology Co., Ltd. Cartographie de caractéristiques de surface moléculaire 3d de capsides d'aav

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010088A1 (fr) 1996-09-06 1998-03-12 Trustees Of The University Of Pennsylvania Procede inductible de production de virus adeno-associes recombines au moyen de la polymerase t7
US9329169B2 (en) * 2007-10-29 2016-05-03 University Of Georgia Research Foundation, Inc Vivo isotopic labeling method for quantitative glycomics
PL2975051T3 (pl) 2009-06-26 2021-09-20 Regeneron Pharmaceuticals, Inc. Wyizolowane z łatwością dwuswoiste przeciwciała o formacie natywnej immunoglobuliny
JP6062860B2 (ja) 2010-10-29 2017-01-18 コヒーシブ・テクノロジーズ・インコーポレイテッド 広範囲の疎水性を有する被検成分の精製及び検出のためのｌｃ−ｍｓ構成
US8946395B1 (en) * 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
EP2975401B1 (fr) 2014-07-18 2019-12-25 Hexal AG Procédé amélioré de mise en correspondance de glycanes de glycoprotéines dans des échantillons de sérum
JPWO2018003559A1 (ja) 2016-07-01 2019-02-07 日立オートモティブシステムズ株式会社 燃料噴射弁
TN2019000047A1 (en) * 2016-08-15 2020-07-15 Genzyme Corp Methods for detecting aav
CN107228912A (zh) * 2017-05-26 2017-10-03 河南省兽药饲料监察所 一种动物性食品中79种抗菌药物的筛查方法

Also Published As

Publication number Publication date
BR112021007550A2 (pt) 2021-07-27
EP3870976B1 (fr) 2023-11-29
EP4306961A2 (fr) 2024-01-17
JP7439077B2 (ja) 2024-02-27
JP2023021996A (ja) 2023-02-14
US20220275398A1 (en) 2022-09-01
WO2020086893A1 (fr) 2020-04-30
EP4306961A3 (fr) 2024-04-17
CN113272649B (zh) 2024-03-12
EA202191137A1 (ru) 2021-10-06
US11345929B2 (en) 2022-05-31
US20200131533A1 (en) 2020-04-30
MX2021004533A (es) 2021-08-24
US20240084328A1 (en) 2024-03-14
US20200299728A1 (en) 2020-09-24
US20240102046A9 (en) 2024-03-28
IL282411A (en) 2021-06-30
AU2019366983A1 (en) 2021-05-13
CN117969861A (zh) 2024-05-03
US11359213B2 (en) 2022-06-14
CN113272649A (zh) 2021-08-17
JP2022505687A (ja) 2022-01-14
PL3870976T3 (pl) 2024-04-08
EP3870976A1 (fr) 2021-09-01
KR20210082183A (ko) 2021-07-02
CA3115832A1 (fr) 2020-04-30

Similar Documents

Publication Publication Date Title
IL282411A (en) Methods for analyzing viral capsid protein composition
IL263801A (en) Novel adeno-associated virus capsid proteins
SG11202106666UA (en) Methods for rna analysis
ZA202102034B (en) Anti-hla-g antibodies, compositions comprising anti-hla-g antibodies and methods of using anti-hla-g antibodies
IL254242A0 (en) Dual signaling fusion proteins and methods of using them to treat diseases
ZA202006604B (en) Method for selection of high m6p recombinant proteins
DK3740222T3 (da) Modificeret RAAV-capsidprotein til genterapi
EP3423091A4 (fr) Compositions et procédés pour induire des anticorps du vih-1
SG11202012529VA (en) Means and methods for increased protein expression by use of transcription factors
GB2591194B (en) Modulation of gene expression and screening for deregulated protein expression
EP3589315A4 (fr) Compositions et procédés pour induire des anticorps anti-vih-1
IL275910A (en) Methods for viral nucleic acid analysis
IL277797A (en) Methods for preparing stable protein preparations
IL292625A (en) Viruses with adapted capsid proteins
EP3893931A4 (fr) Méthodes d'utilisation d'anticorps anti-trem2
EP4069288A4 (fr) Méthodes de traitement à l'aide de protéines de liaison à l'ilt7
IL278220A (en) Methods for the purification of polypeptides using polysorbates
IL292145A (en) Methods for protein characterization in host cells
SG11202009854XA (en) Modified viral capsids
DK3399040T3 (da) Fremgangsmåde til fremstilling af porcine circovirus type 2 capsid-protein og farmaceutisk sammensætning omfattende samme
ZA202101433B (en) An improved process for the preparation of recombinant lectin protein
IL268600A (en) A method for determining the potency of adeno-associated virus preparations
ZA202104083B (en) Viral inactivation methods for continuous manufacturing of antibodies
EP3452038A4 (fr) Procédé de préparation d'intermédiaires utiles dans la préparation d'inhibiteurs du virus de l'hépatite c (vhc)
EP3634450A4 (fr) Procédés et compositions pour modifier la dépendance à une protéine activant l'assemblage (app) de virus